David Pernock
2013 - Fibrocell Science
In 2013, David Pernock earned a total compensation of $2.8M as Chairman of the Board and Chief Executive Officer at Fibrocell Science, a 522% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,344,412 |
|---|---|
| Salary | $454,769 |
| Total | $2,799,181 |
Pernock received $2.3M in option awards, accounting for 84% of the total pay in 2013.
Pernock also received $454.8K in salary.
Rankings
In 2013, David Pernock's compensation ranked 2,745th out of 12,286 executives tracked by ExecPay. In other words, Pernock earned more than 77.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,745 out of 12,286 | 78th |
Division Manufacturing | 911 out of 4,612 | 80th |
Major group Chemicals And Allied Products | 238 out of 1,462 | 84th |
Industry group Drugs | 159 out of 1,156 | 86th |
Industry Pharmaceutical Preparations | 133 out of 890 | 85th |
Source: SEC filing on April 29, 2016.
Pernock's colleagues
We found two more compensation records of executives who worked with David Pernock at Fibrocell Science in 2013.
News
Eagle Pharmaceuticals CEO Scott Tarriff's 2021 pay falls 32% to $6.5M
June 15, 2022
Eagle Pharmaceuticals CEO Scott Tarriff's 2020 pay rises 20% to $9.5M
April 30, 2021
Eagle Pharmaceuticals CEO Scott Tarriff's 2019 pay falls 30% to $7.9M
April 29, 2020
Eagle Pharmaceuticals CEO Scott Tarriff's 2018 pay jumps 41% to $11M
April 30, 2019